These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2829861)

  • 1. Reconstitution of the purified receptor for calcium channel blockers.
    Sieber M; Nastainczyk W; Röhrkasten A; Hofmann F
    Biomed Biochim Acta; 1987; 46(8-9):S357-62. PubMed ID: 2829861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purified dihydropyridine-binding site from skeletal muscle t-tubules is a functional calcium channel.
    Flockerzi V; Oeken HJ; Hofmann F; Pelzer D; Cavalié A; Trautwein W
    Nature; 1986 Sep 4-10; 323(6083):66-8. PubMed ID: 2427959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
    Reynolds IJ; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of a functional receptor for calcium-channel blockers from rabbit skeletal-muscle microsomes.
    Flockerzi V; Oeken HJ; Hofmann F
    Eur J Biochem; 1986 Nov; 161(1):217-24. PubMed ID: 3023084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Solubilization and isolation of dihydropyridine calcium channel blocker receptor from the rabbit skeletal muscle].
    Soldatov NM
    Biokhimiia; 1988 Sep; 53(9):1418-26. PubMed ID: 2849480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.
    Schmid A; Romey G; Barhanin J; Lazdunski M
    Mol Pharmacol; 1989 Jun; 35(6):766-73. PubMed ID: 2543910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.
    Glossmann H; Ferry DR; Goll A; Rombusch M
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S608-21. PubMed ID: 6083403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dihydropyridine receptor: expression of 190 kD alpha 1 subunit in crayfish muscle.
    Hudecová S; Krizanová O
    Gen Physiol Biophys; 1991 Jun; 10(3):299-307. PubMed ID: 1655559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of SR 33557 with skeletal muscle calcium channel blocker receptors in the baboon: characterization of its binding sites.
    Sol-Rolland J; Joseph M; Rinaldi-Carmona M
    J Pharmacol Exp Ther; 1991 May; 257(2):595-602. PubMed ID: 1851830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
    Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F
    Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
    Balwierczak JL; Johnson CL; Schwartz A
    Mol Pharmacol; 1987 Feb; 31(2):175-9. PubMed ID: 2433570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
    Haase H; Wallukat G; Vetter R; Will H
    Biomed Biochim Acta; 1987; 46(8-9):S363-9. PubMed ID: 2829862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular properties of voltage-sensitive calcium channels.
    Catterall WA; Curtis BM
    Soc Gen Physiol Ser; 1987; 41():201-13. PubMed ID: 2436311
    [No Abstract]   [Full Text] [Related]  

  • 15. [Isolation and characteristics of dihydropyridine calcium antagonist receptor from rabbit skeletal muscles].
    Soldatov NM
    Biokhimiia; 1988 Oct; 53(10):1600-11. PubMed ID: 2852965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
    Hagiwara M; Adachi-Akahane S; Nagao T
    J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker.
    Suh-Kim H; Wei X; Birnbaumer L
    Mol Pharmacol; 1996 Nov; 50(5):1330-7. PubMed ID: 8913365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The devapamil-binding site of the purified skeletal muscle receptor for organic-calcium channel blockers is modulated by micromolar and millimolar concentrations of Ca2+.
    Schneider T; Regulla S; Hofmann F
    Eur J Biochem; 1991 Aug; 200(1):245-53. PubMed ID: 1652439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of the dihydropyridine receptor of the voltage-dependent Ca2+ channel from skeletal muscle transverse tubules using (+) [3H]PN 200-110.
    Borsotto M; Barhanin J; Norman RI; Lazdunski M
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1357-66. PubMed ID: 6089781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purified calcium channels have three allosterically coupled drug receptors.
    Striessnig J; Goll A; Moosburger K; Glossmann H
    FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.